Literature DB >> 4962702

Role of complement in immune inactivation of Mycoplasma gallisepticum.

L F Barker, J K Patt.   

Abstract

Studies were undertaken to evaluate the role of complement in the interaction between mycoplasmas and antiserum. A suspension of the A-1 strain of Mycoplasma gallisepticum in PPLO broth was incubated at 37 C with rabbit immune serum which had been heated for 30 min at 56 C. Samples were removed from the mixture at timed intervals for 1 hr for titration of the mycoplasmas in broth. When normal guinea pig serum was included in the mixture at a final dilution of 1:40, the titer fell rapidly from 10(6) to 10(2) organisms per 0.2 ml. When the guinea pig serum was heated for 30 min at 56 C or was omitted from the mixture, the immune serum did not reduce the titer. The rate of inactivation was related to the final concentration of antiserum and to the incubation temperature. The effect of the guinea pig serum was eliminated by the addition of 0.01 m sodium ethylenediaminetetraacetate or by prior absorption with an unrelated antigen-antibody complex. It was concluded that complement-like substances play an important role in immune inactivation of M. gallisepticum.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4962702      PMCID: PMC315054          DOI: 10.1128/jb.94.2.403-408.1967

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  12 in total

1.  LESIONS IN ERYTHROCYTE MEMBRANES CAUSED BY IMMUNE HAEMOLYSIS.

Authors:  T BORSOS; R R DOURMASHKIN; J H HUMPHREY
Journal:  Nature       Date:  1964-04-18       Impact factor: 49.962

2.  MYCOPLASMA SPECIES IDENTIFICATION BASED UPON GROWTH INHIBITION BY SPECIFIC ANTISERA.

Authors:  W A CLYDE
Journal:  J Immunol       Date:  1964-06       Impact factor: 5.422

3.  Antigenic properties of pleuropneumonia-like organisms from tissue cell cultures and the human genital area.

Authors:  J S Bailey; H W Clark; W R Felts; R C Fowler; T M Brown
Journal:  J Bacteriol       Date:  1961-10       Impact factor: 3.490

4.  Microorganisms of the Pleuropneumonia group (family of Mycoplasmataceae) in man. II. Serological identification and discussion of pathogenicity.

Authors:  A G HUIJSMANS-EVERS; A C RUYS
Journal:  Antonie Van Leeuwenhoek       Date:  1956       Impact factor: 2.271

5.  Inhibition of growth of pleuropneumonia-like organisms by antibody.

Authors:  D G EDWARD; W A FITZGERALD
Journal:  J Pathol Bacteriol       Date:  1954-07

6.  The reactivity of serum against protoplasts and spheroplasts.

Authors:  L H Muschel; J E Jackson
Journal:  J Immunol       Date:  1966-07       Impact factor: 5.422

7.  Identification of the A-1 agent as Mycoplasma gallisepticum.

Authors:  J P O'Malley; Z A McGee; M F Barile; L F Barker
Journal:  Proc Natl Acad Sci U S A       Date:  1966-09       Impact factor: 11.205

8.  CYTOPATHIC EFFECT OF THE ATYPICAL PNEUMONIA ORGANISM IN CULTURES OF HUMAN TISSUE.

Authors:  M D Eaton; A E Farnham; J D Levinthal; A R Scala
Journal:  J Bacteriol       Date:  1962-12       Impact factor: 3.490

9.  Effect of culture medium on antigenic structure of mycoplasma.

Authors:  S C Smith; W R Dunlop; R G Strout
Journal:  Avian Dis       Date:  1966-05       Impact factor: 1.577

10.  ULTRASTRUCTURE OF MYCOPLASMA SPECIES.

Authors:  C H DOMERMUTH; M H NIELSEN; E A FREUNDT; A BIRCH-ANDERSEN
Journal:  J Bacteriol       Date:  1964-09       Impact factor: 3.490

View more
  12 in total

1.  Interactions between Mycoplasma pneumoniae and guinea pig complement.

Authors:  W Bredt; D Bitter-Suermann
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

2.  Antibodies to Acholeplasma laidlawii membrane lipids in normal guinea pig serum.

Authors:  I Dörner; H Brunner; H G Schiefer; M Loos; H J Wellensiek
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

3.  Modifications of the growth inhibition test and its application to human T-mycoplasmas.

Authors:  F T Black
Journal:  Appl Microbiol       Date:  1973-04

4.  Some effects of growth medium composition on the antigenicity of a T-strain mycoplasma.

Authors:  G K Masover; R P Mischak; L Hayflick
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

5.  Optimal strategies in immunology III. The IgM-IgG switch.

Authors:  A S Perelson; B Goldstein; S Rocklin
Journal:  J Math Biol       Date:  1980-11       Impact factor: 2.259

6.  Interactions between mycoplasma pneumoniae and the first components of complement.

Authors:  W Bredt; B Wellek; H Brunner; M Loos
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

7.  Detection and characterization of defective mycoplasmacidal antibody produced by rodents against Mycoplasma arthritidis.

Authors:  B C Cole; J R Ward
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

8.  Variation in the susceptibility of bovine mycoplasmas to killing by the alternative complement pathway in bovine serum.

Authors:  C J Howard
Journal:  Immunology       Date:  1980-11       Impact factor: 7.397

9.  Interaction of porcine mycoplasmas with fresh animal serum.

Authors:  D H Roberts
Journal:  J Hyg (Lond)       Date:  1971-09

10.  Complement-mediated killing of Acholeplasma laidlawii by antibodies to various membrane components.

Authors:  I Dörner; H Brunner; H G Schiefer; H J Wellensiek
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.